MedPath

Postoperative pain relief and analgesia after laproscopic cholecystectomy: bupivacaine versus nalbuphine ,when instilled through the laprpscopic port

Phase 4
Conditions
Health Condition 1: 3- AdministrationHealth Condition 2: K800- Calculus of gallbladder with acutecholecystitis
Registration Number
CTRI/2020/11/028869
Lead Sponsor
Hakeem Abdul Centenary hospitalNew Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Eighty patients ( 40 in each group) with ASA 1,2, aged 18-60 years, undergoing laproscopic cholecystectomy were be included in the study.

Exclusion Criteria

Patients with H/o chronic opioid intake

Known allergy to local anaesthetics,

Obese or pregnant patients were excluded from the study.

Patients those who have chronic pain diseases (not related to choleystitis) or have acute cholecystitis before the surgery were also be excluded

When the duration of surgery exceeded 2 hrs or if the surgery got converted to open, were also excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to compare and assess the VAS score at different intervals and to determine the time of first analgesic request.Timepoint: post operative ,2 ,4 ,6 hrs upto 24 hrs
Secondary Outcome Measures
NameTimeMethod
to compare the analgesic request rate ( number of doses of tramadol in 24 hrs), patient satisfaction score , incidence of shoulder pain and time to return to normal activity.Timepoint: uptl 24 hrs
© Copyright 2025. All Rights Reserved by MedPath